SZodixStudyAcademic Library

Dashboard Shelves Open access My library Inbox Notes Write Learn Alerts

More

Ask your library Notifications Quick cite Review

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

The Current Status of Psychedelics in Psychiatry · Study

ArticleShelves

ArticleThe Current Status of Psychedelics in Psychiatry

David Nutt2020

Article2020

The Current Status of Psychedelics in Psychiatry

David Nutt · Robin Lester Carhart-Harris

223 citations·0/0 files stored·JAMA Psychiatry

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Psychedelics and Drug Studies Schizophrenia research and treatment Treatment of Major Depression

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 223 citations exist upstream.

References

2016Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial 2016Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial 2006Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance 2016Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study 2012Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin 2017Psychiatry & the psychedelic drugs. Past, present & future

Cited by

2022Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study 2023Case analysis of long-term negative psychological responses to psychedelics 2022Expectancy in placebo-controlled trials of psychedelics: if so, so what?2023A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression 2022Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2019Cessation and reduction in alcohol consumption and misuse after psychedelic usearticle · 6 shared references 2020Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanismsreview · 6 shared references 2022Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical reviewreview · 6 shared references 2018Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventionsreview · 6 shared references 2020Pivotal mental statesreview · 6 shared references 2019REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelicsarticle · 5 shared references

Details

Year2020

Typearticle

Published2020-07-29

VenueJAMA Psychiatry

ISSN-L2168-622X

Languageen

Citations223

Files0 public / 0

ShelfPsychedelics and Drug Studies

Identifiers

doi10.1001/jamapsychiatry.2020.2171

openalex_workW3046100757

Links

Imported from OpenAlex (CC0) — nothing here is generated.

2022Neural Mechanisms and Psychology of Psychedelic Ego Dissolution

2021Psychedelic perceptions: mental health service user attitudes to psilocybin therapy

2022Lower-dose psycholytic therapy – A neglected approach